BBC News -- Researchers from Ghent University in Belgium said there could be “serious clinical consequences” for patients. Tablets which have a narrow margin between a dose that is therapeutic and one that is toxic are riskiest.
BBC News -- Researchers from Ghent University in Belgium said there could be “serious clinical consequences” for patients. Tablets which have a narrow margin between a dose that is therapeutic and one that is toxic are riskiest.